FDA approves first pill to prevent recurrent C. difficile infections聽
The Food and Drug Administration the first fecal microbiota product taken orally to prevent recurrent C. difficile infection.
鈥淭oday鈥檚 approval provides patients and healthcare providers a new way to help prevent recurrent C. difficile infection,鈥 Peter Marks, M.D., director of the FDA鈥檚 Center for Biologics Evaluation and Research. 鈥淭he availability of a fecal microbiota product that can be taken orally is a significant step forward in advancing patient care and accessibility for individuals who have experienced this disease that can be potentially life-threatening.鈥
Related News Articles
Headline
Ochsner Health's Stephen Saenz, sepsis program manager, and Teresa Arrington, director of robust process improvement for quality and patient safety, reveal how鈥
Headline
The Centers for Disease Control and Prevention has added new resources for health care providers to its Be Ready for Measles Toolkit. They include a decision鈥
Headline
There have been 1,168 confirmed cases of measles across 33 states as of June 6 this year, according to the latest data from the Centers for Disease Control and鈥
Headline
A JAMA study published June 3 found that of 2,237 counties across the U.S., 78% reported declines in vaccination rates for measles, mumps and rubella from 2019鈥
Headline
There have been 1,024 confirmed cases of measles across the U.S. so far in 2025, according to the latest data from the Centers for Disease Control and鈥
Headline
There have been 1,001 confirmed cases of measles across the U.S. so far in 2025, according to the latest data from the Centers for Disease Control and鈥